Free Trial
CVE:BTI

Bioasis Technologies (BTI) Stock Price, News & Analysis

Bioasis Technologies logo
C$0.0050 -0.01 (-50.00%)
As of 03/18/2024

About Bioasis Technologies Stock (CVE:BTI)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.03
Volume
5,250 shs
Average Volume
73,137 shs
Market Capitalization
C$397.05 thousand
P/E Ratio
N/A
Dividend Yield
40,400.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioasis Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTI Stock News Headlines

RBT Rubicon Technologies, Inc.
This Coin Could Explode, and it’s Hiding in Plain Sight!
The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...tc pixel
Bioasis Technologies Inc BIOAF
Closing Bell: Bioasis Technologies Inc down on Friday (BTI)
See More Headlines

BTI Stock Analysis - Frequently Asked Questions

Bioasis Technologies' stock was trading at C$0.01 at the beginning of 2025. Since then, BTI shares have increased by 0.0% and is now trading at C$0.01.

Shares of BTI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioasis Technologies investors own include Achaogen (AKAO), Biora Therapeutics (BIOR), Bristol Myers Squibb (BMY), Novavax (NVAX), Ocugen (OCGN), Pfizer (PFE) and

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Tobacco Products
Current Symbol
CVE:BTI
CIK
N/A
Fax
N/A
Employees
52,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.88 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-80.58%

Debt

Debt-to-Equity Ratio
27.88
Current Ratio
0.11
Quick Ratio
0.17

Sales & Book Value

Annual Sales
C$158.17 thousand
Price / Sales
2.51
Cash Flow
C$0.00 per share
Price / Cash Flow
13.57
Book Value
C($0.03) per share
Price / Book
-0.17

Miscellaneous

Outstanding Shares
79,410,000
Free Float
N/A
Market Cap
C$397.05 thousand
Optionable
Not Optionable
Beta
0.45
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:BTI) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners